See the DrugPatentWatch profile for cosentyx

For patients with allergic psoriasis seeking an alternative to Cosentyx (secukinumab), several other medications may be considered. These include:

1. Enbrel (etanercept): Enbrel is a tumor necrosis factor (TNF) blocker that can be used to treat psoriasis. It is administered subcutaneously and has been shown to be effective in reducing psoriasis symptoms. However, it may have a slower onset of action compared to Cosentyx [1].

2. Humira (adalimumab): Humira is another TNF blocker that can be used to treat psoriasis. It is administered subcutaneously and has been shown to be effective in reducing psoriasis symptoms. Like Enbrel, it may have a slower onset of action compared to Cosentyx [1].

3. Stelara (ustekinumab): Stelara is an interleukin (IL)-12 and IL-23 inhibitor that can be used to treat psoriasis. It is administered subcutaneously and has been shown to be effective in reducing psoriasis symptoms. It has a similar onset of action to Cosentyx [1].

4. Tremfya (guselkumab): Tremfya is an IL-23 inhibitor that can be used to treat psoriasis. It is administered subcutaneously and has been shown to be effective in reducing psoriasis symptoms. It has a similar onset of action to Cosentyx [1].

5. Siliq (brodalumab): Siliq is an IL-17 receptor inhibitor that can be used to treat psoriasis. It is administered subcutaneously and has been shown to be effective in reducing psoriasis symptoms. However, it has a boxed warning for increased risk of suicidal ideation and behavior [1].

It is important to note that these medications may not be suitable for all patients and may have different side effect profiles. Patients should consult with their healthcare provider to determine the most appropriate treatment option for their individual needs.

Sources:
[1] DrugPatentWatch.com. (n.d.). Psoriasis. Retrieved from <https://www.drugpatentwatch.com/disease/psoriasis/>